Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
Conditions
- Endometrial Adenocarcinoma
- Endometrial Adenosquamous Carcinoma
- Endometrial Clear Cell Adenocarcinoma
- Recurrent Uterine Corpus Carcinoma
Interventions
- DRUG: Gemcitabine Hydrochloride
Sponsor
Gynecologic Oncology Group
Collaborators